Peptides Are Booming— in a Medical Gray Zone

People are lining up—and in some cases paying five figures a year—to inject substances the FDA hasn't signed off on. In the New Yorker , physician-writer Dhruv Khullar digs into the booming world of peptides: short amino-acid chains sold as everything from injury repair tools to longevity hacks. The...